Evidence map›Paper›PMID 39190708›Full record

ArticleScience signaling2024

Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes.

Jamil Mahmud, Brittany W Geiler, Juthi Biswas, Michael J Miller, Julia E Myers, Stephen M Matthews, Amanda B Wass, Christine M O'Connor, Gary C Chan

Abstract read
In one paragraph

Article in Science signaling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. A comprehensive method for quantifying human cytomegalovirus plaque assays.Frontiers in cellular and infection microbiology · 2026
    Article
  5. Cytomegalovirus disrupts Lamin A/C to control microtubule-mediated nuclear movement and cell migration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jamil MahmudDepartment of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.ORCID 0000-0003-3091-2046
Brittany W GeilerDepartment of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.ORCID 0000-0003-2032-5323
Juthi BiswasDepartment of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Michael J MillerDepartment of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.ORCID 0000-0001-6523-8974
Julia E MyersInfection Biology, Lerner Research Institute, Sheikha Fatima bint Mubarak Global Center for Pathogen and Human Health Research, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-5371-8361
Stephen M MatthewsInfection Biology, Lerner Research Institute, Sheikha Fatima bint Mubarak Global Center for Pathogen and Human Health Research, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-8968-225X
Amanda B WassInfection Biology, Lerner Research Institute, Sheikha Fatima bint Mubarak Global Center for Pathogen and Human Health Research, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0001-7712-6259
Christine M O'ConnorInfection Biology, Lerner Research Institute, Sheikha Fatima bint Mubarak Global Center for Pathogen and Human Health Research, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0003-4943-3774
Gary C ChanDepartment of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.ORCID 0000-0001-8209-9777

Funding

Novel Anti-HCMV StrategiesR01HL139824 · NHLBI · UPSTATE MEDICAL UNIVERSITY · PI CHAN, GARY CHING TAO · 2018 to 2021
$3.0M
Mechanisms of HCMV-induced monocyte-to-macrophage differentiation.R01AI141460 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI CHAN, GARY CHING TAO · 2019 to 2023
$2.7M
Targeting Nuclear HSF1 as a Novel Anti-HCMV StrategyR01AI170834 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI Gary Ching Tao Chan · 2023 to 2026
$2.6M
HCMV GPCR functions during latency and reactivationR01AI153348 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI O'CONNOR, CHRISTINE M · 2021 to 2025
$2.2M
NHLBI NIH HHS R01 HL139824NIAID NIH HHS R01 AI141460NIAID NIH HHS R01 AI153348NIAID NIH HHS R01 AI170834
6 · The paper itself

Abstract

Establishing a nonproductive, quiescent infection within monocytes is essential for the spread of human cytomegalovirus (HCMV). We investigated the mechanisms through which HCMV establishes a quiescent infection in monocytes. US28 is a virally encoded G protein-coupled receptor (GPCR) that is essential for silent infections within cells of the myeloid lineage. We found that preformed US28 was rapidly delivered to monocytes by HCMV viral particles, whereas the de novo synthesis of US28 was delayed for several days. A recombinant mutant virus lacking US28 (US28Δ) was unable to establish a quiescent infection, resulting in a fully productive lytic infection able to produce progeny virus. Infection with US28Δ HCMV resulted in the phosphorylation of the serine and threonine kinase Akt at Ser

Indexed as

CytomegalovirusErbB ReceptorsMonocytesProto-Oncogene Proteins c-aktViral ProteinsVirus ReplicationCytomegalovirus InfectionsHumansPhosphorylationReceptors, ChemokineSignal TransductionVirionEGFR protein, humanErbB ReceptorsProto-Oncogene Proteins c-aktReceptors, ChemokineUS28 receptor, CytomegalovirusViral Proteins

Identifiers

PMID39190708
PMCPMC11460310

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.